» Articles » PMID: 37724279

The Prevalence of Red-green Color Vision Deficiency and Its Related Factors in an Elderly Population Above 60 Years of Age

Overview
Specialty Ophthalmology
Date 2023 Sep 19
PMID 37724279
Authors
Affiliations
Soon will be listed here.
Abstract

Aim: To determine the prevalence of red-green (RG) color vision deficiency (CVD) in an elderly population and its related factors.

Methods: This report is a part of the Tehran Geriatric Eye Study: a cross-sectional population-based study that was conducted on the elderly population (≥60y) of Tehran, Iran using multi-stage stratified random cluster sampling. All study participants underwent complete ocular examination, including the measurement of uncorrected and best-corrected visual acuity, objective and subjective refraction, and slit-lamp biomicroscopy. The color vision was tested using Ishihara plates with the near optical correction in place.

Results: Of the 3791 invitees, 3310 participated in the study. The data of 2164 individuals were analyzed after applying the exclusion criteria. The prevalence of R-G CVD was 3.73% (95%CI: 2.37%-5.09%) in the whole sample; the prevalence of protanomaly, protanopia, and deuteranopia was 1.51%, 1.76%, and 0.45%, respectively. The prevalence of R-G CVD was significantly higher in males than in females. The prevalence of RG CVD increased with advancing age from 2.91% in the age group 60-64y to 5.8% in the age group ≥80y (=0.070). According to the multiple logistic regression model, male sex, and glaucoma were significantly related to RG CVD. Older age and hypertension also had a marginally significant relationship with RG CVD.

Conclusion: Changes in color vision occur in the elderly due to the aging process and some physiological and pathological factors. Since the change in visual perception may affect the person's performance, this aspect of the visual system's function should also be taken into consideration in the examinations of the elderly.

Citing Articles

Photobiomodulation therapy for congenital color vision deficiency: results of a preliminary randomized clinical trial.

Liu Y, Yang Q, Yu J, Jia L Front Med (Lausanne). 2025; 11:1497501.

PMID: 39748919 PMC: 11693665. DOI: 10.3389/fmed.2024.1497501.

References
1.
Raman R, Verma A, Srinivasan S, Bhojwani D . Partial reversal of color vision impairment in type 2 diabetes associated with obstructive sleep apnea. GMS Ophthalmol Cases. 2018; 8:Doc05. PMC: 5854760. DOI: 10.3205/oc000087. View

2.
Ahadi M, Ebrahimi A, Rahmani S, Baghban A . Prevalence of refractive errors and color vision deficiency in a population of industry-workers in Abhar, Iran. Medicine (Baltimore). 2021; 100(46):e27758. PMC: 8601269. DOI: 10.1097/MD.0000000000027758. View

3.
Piro A, Tagarelli A, Nicoletti G, Scannapieco S, Polidoro S, Valentino P . Impairment of acquired color vision in multiple sclerosis: an early diagnostic sign linked to the greatness of disease. Int Ophthalmol. 2018; 39(3):671-676. DOI: 10.1007/s10792-018-0838-x. View

4.
Wolff B, Bearse Jr M, Schneck M, Dhamdhere K, Harrison W, Barez S . Color vision and neuroretinal function in diabetes. Doc Ophthalmol. 2014; 130(2):131-9. PMC: 4459591. DOI: 10.1007/s10633-014-9476-4. View

5.
Kuebler A, Halfter K, Reznicek L, Klingenstein A, Priglinger S, Rudolph G . A pathological indicator for dysthyroid optic neuropathy: tritan color vision deficiency. Graefes Arch Clin Exp Ophthalmol. 2021; 259(11):3421-3426. PMC: 8523501. DOI: 10.1007/s00417-021-05227-8. View